Search

Your search keyword '"Golan, Maya"' showing total 198 results

Search Constraints

Start Over You searched for: Author "Golan, Maya" Remove constraint Author: "Golan, Maya"
198 results on '"Golan, Maya"'

Search Results

1. Evaluating the Effectiveness of Accommodations Given to Students with Learning Impairments: Ordinal and Interpretable Machine-Learning-Based Methodology

2. Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases

6. Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

7. Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable

9. Evaluation of the Effect of Learning Disabilities and Accommodations on the Prediction of the Stability of Academic Behaviour of Undergraduate Engineering Students Using Decision Trees

10. Integrating Actual Time Usage into the Assessment of Examination Time Extensions Provided to Disabled College Engineering Students

11. Oral Administration of a Novel Small Molecule Blocks the BMP Canonical and the Non-canonical BMP2, BMP4, and BMP5 Signaling Pathways Ameliorates EAE Through Oligodendrogenesis Remyelination and Preservation of Axonal Integrity and Reduces Astrogenesis (P7-6.015)

25. A framework for operator – workstation interaction in Industry 4.0.

28. Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study

30. Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab : A Real-World Multicenter European Study

31. Tu1497: COMPARISON OF THE RISK OF CLINICAL RECURRENCE AFTER ILEOCOLONIC RESECTION FOR CROHN'S DISEASE FOR MODIFIED RUTGEERTS’ SCORE I2A AND I2B CATEGORIES: INDIVIDUAL PATIENT DATA META-ANALYSIS.

32. Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES

33. Decreased Immune Response to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases Treated with Anti TNFα

34. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

36. Decreased Immune Response to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases Treated with Anti TNFα

40. Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.

42. Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases

44. Artificial Intelligence Successfully Identifies Subjects Who are at High Risk for Colorectal Cancer and Will Not Show Up for Colonoscopy within Six Months Following a Positive Fecal Occult Blood Test

45. Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

46. Sa1773 POST-OPERATIVE PROPHYLAXIS WITH ANTI-TNF IN PATIENTS WITH CROHN'S DISEASE WHO ARE ANTI-TNF EXPERIENCED IS ASSOCIATED WITH HIGHER RATES OF PROPHYLAXIS FAILURE

Catalog

Books, media, physical & digital resources